vs
Cytosorbents Corp（CTSO）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
RETRACTABLE TECHNOLOGIES INC的季度营收约是Cytosorbents Corp的1.0倍（$9.4M vs $9.2M），RETRACTABLE TECHNOLOGIES INC净利率更高（-24.9% vs -59.5%，领先34.7%），RETRACTABLE TECHNOLOGIES INC同比增速更快（4.0% vs 0.9%），过去两年RETRACTABLE TECHNOLOGIES INC的营收复合增速更高（11.5% vs 1.3%）
Cytosorbents是一家公开上市企业，总部位于美国新泽西州普林斯顿，专注于血液净化领域相关医疗产品的研发与商业化，核心产品应用于重症救治场景，帮助去除患者血液中的炎性介质等有害物质。
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
CTSO vs RVP — 直观对比
营收规模更大
RVP
是对方的1.0倍
$9.2M
营收增速更快
RVP
高出3.1%
0.9%
净利率更高
RVP
高出34.7%
-59.5%
两年增速更快
RVP
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $9.4M |
| 净利润 | $-5.5M | $-2.3M |
| 毛利率 | 73.7% | -16.2% |
| 营业利润率 | -47.5% | -81.7% |
| 净利率 | -59.5% | -24.9% |
| 营收同比 | 0.9% | 4.0% |
| 净利润同比 | 27.4% | -162.3% |
| 每股收益（稀释后） | $-0.09 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTSORVP
| Q4 25 | $9.2M | $9.4M | ||
| Q3 25 | $9.5M | $10.1M | ||
| Q2 25 | $9.6M | $10.4M | ||
| Q1 25 | $8.7M | $8.3M | ||
| Q4 24 | $9.2M | $9.1M | ||
| Q3 24 | $8.6M | $10.3M | ||
| Q2 24 | $8.8M | $6.0M | ||
| Q1 24 | $9.0M | $7.6M |
净利润CTSORVP
| Q4 25 | $-5.5M | $-2.3M | ||
| Q3 25 | $-3.2M | $371.0K | ||
| Q2 25 | $1.9M | $-87.5K | ||
| Q1 25 | $-1.5M | $-10.5M | ||
| Q4 24 | $-7.6M | $3.8M | ||
| Q3 24 | $-2.8M | $-1.9M | ||
| Q2 24 | $-4.3M | $-14.2M | ||
| Q1 24 | $-6.1M | $429.4K |
毛利率CTSORVP
| Q4 25 | 73.7% | -16.2% | ||
| Q3 25 | 70.3% | 16.7% | ||
| Q2 25 | 70.9% | -1.0% | ||
| Q1 25 | 71.1% | -0.0% | ||
| Q4 24 | 68.4% | -27.5% | ||
| Q3 24 | 61.0% | -0.1% | ||
| Q2 24 | 73.5% | -7.0% | ||
| Q1 24 | 76.5% | 25.0% |
营业利润率CTSORVP
| Q4 25 | -47.5% | -81.7% | ||
| Q3 25 | -30.2% | -36.2% | ||
| Q2 25 | -37.6% | -49.1% | ||
| Q1 25 | -44.5% | -56.4% | ||
| Q4 24 | -37.1% | -79.6% | ||
| Q3 24 | -56.1% | -49.6% | ||
| Q2 24 | -40.4% | -95.6% | ||
| Q1 24 | -51.8% | -39.3% |
净利率CTSORVP
| Q4 25 | -59.5% | -24.9% | ||
| Q3 25 | -33.4% | 3.7% | ||
| Q2 25 | 20.2% | -0.8% | ||
| Q1 25 | -16.9% | -126.6% | ||
| Q4 24 | -82.7% | 41.6% | ||
| Q3 24 | -32.1% | -18.6% | ||
| Q2 24 | -48.6% | -234.9% | ||
| Q1 24 | -67.7% | 5.7% |
每股收益（稀释后）CTSORVP
| Q4 25 | $-0.09 | $-0.09 | ||
| Q3 25 | $-0.05 | $0.01 | ||
| Q2 25 | $0.03 | $0.00 | ||
| Q1 25 | $-0.02 | $-0.35 | ||
| Q4 24 | $-0.14 | $0.14 | ||
| Q3 24 | $-0.05 | $-0.07 | ||
| Q2 24 | $-0.08 | $-0.48 | ||
| Q1 24 | $-0.11 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.2M | $2.6M |
| 总债务越低越好 | — | $895.6K |
| 股东权益账面价值 | $5.9M | $74.4M |
| 总资产 | $44.2M | $142.6M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CTSORVP
| Q4 25 | $6.2M | $2.6M | ||
| Q3 25 | $7.5M | $3.4M | ||
| Q2 25 | $10.2M | $3.0M | ||
| Q1 25 | $11.6M | $3.4M | ||
| Q4 24 | $3.3M | $4.2M | ||
| Q3 24 | $5.7M | $3.9M | ||
| Q2 24 | $8.5M | $6.9M | ||
| Q1 24 | $8.6M | $10.0M |
总债务CTSORVP
| Q4 25 | — | $895.6K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $4.4M | — |
股东权益CTSORVP
| Q4 25 | $5.9M | $74.4M | ||
| Q3 25 | $9.0M | $76.8M | ||
| Q2 25 | $11.6M | $76.5M | ||
| Q1 25 | $14.5M | $76.6M | ||
| Q4 24 | $11.1M | $87.2M | ||
| Q3 24 | $13.4M | $83.5M | ||
| Q2 24 | $17.4M | $85.4M | ||
| Q1 24 | $19.6M | $99.7M |
总资产CTSORVP
| Q4 25 | $44.2M | $142.6M | ||
| Q3 25 | $45.8M | $146.4M | ||
| Q2 25 | $48.0M | $147.1M | ||
| Q1 25 | $50.8M | $149.3M | ||
| Q4 24 | $47.4M | $160.7M | ||
| Q3 24 | $47.8M | $157.8M | ||
| Q2 24 | $53.4M | $160.7M | ||
| Q1 24 | $47.1M | $176.0M |
负债/权益比CTSORVP
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | $-4.9M | — |
| 自由现金流率自由现金流/营收 | -53.4% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.5M | — |
8季度趋势，按日历期对齐
经营现金流CTSORVP
| Q4 25 | $-4.8M | $-596.5K | ||
| Q3 25 | $-2.6M | $-1.3M | ||
| Q2 25 | $-1.5M | $-3.7M | ||
| Q1 25 | $-3.5M | $-1.5M | ||
| Q4 24 | $-2.3M | $-1.1M | ||
| Q3 24 | $-2.5M | $-5.7M | ||
| Q2 24 | $-4.8M | $-2.7M | ||
| Q1 24 | $-4.8M | $-2.0M |
自由现金流CTSORVP
| Q4 25 | $-4.9M | — | ||
| Q3 25 | $-2.6M | $-1.3M | ||
| Q2 25 | $-1.5M | $-4.1M | ||
| Q1 25 | $-3.5M | $-1.6M | ||
| Q4 24 | $-2.4M | $-1.4M | ||
| Q3 24 | $-2.6M | $-6.5M | ||
| Q2 24 | $-4.8M | $-2.8M | ||
| Q1 24 | $-4.9M | $-2.2M |
自由现金流率CTSORVP
| Q4 25 | -53.4% | — | ||
| Q3 25 | -27.3% | -13.4% | ||
| Q2 25 | -16.1% | -38.9% | ||
| Q1 25 | -39.7% | -18.8% | ||
| Q4 24 | -26.3% | -15.5% | ||
| Q3 24 | -30.4% | -63.0% | ||
| Q2 24 | -54.4% | -46.8% | ||
| Q1 24 | -54.2% | -29.6% |
资本支出强度CTSORVP
| Q4 25 | 1.2% | — | ||
| Q3 25 | 0.2% | 0.9% | ||
| Q2 25 | 0.4% | 3.2% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.8% | 3.3% | ||
| Q3 24 | 1.8% | 7.7% | ||
| Q2 24 | 0.2% | 2.0% | ||
| Q1 24 | 0.5% | 3.0% |
现金转化率CTSORVP
| Q4 25 | — | — | ||
| Q3 25 | — | -3.39× | ||
| Q2 25 | -0.78× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
RVP
暂无分部数据
